EMEA (Europe, Middle East and Africa) Sleeping Pills (Prescription Drugs) Market Report 2018

January 2018 | 109 pages | ID: E13E1B82DBBEN
QYResearch

Abstracts

In this report, the EMEA Sleeping Pills (Prescription Drugs) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Sleeping Pills (Prescription Drugs) for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Sleeping Pills (Prescription Drugs) market competition by top manufacturers/players, with Sleeping Pills (Prescription Drugs) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• Abbott Laboratories
• Takeda Pharmaceutical
• Apotex
• Aurobindo Pharma
• Actellon Pharmaceuticals
• Allegiant Health
• Cayman Chemical
• Ambitropin
• Hayao

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Zolpidem
• Eszopiclone (Lunesta)
• Ramelteon (Rozerem)
• Ativan (lorazepam)
• Adapin (doxepin)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital Pharmacy
• Retail Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Sleeping Pills (Prescription Drugs) Market Report 2017

1 SLEEPING PILLS (PRESCRIPTION DRUGS) OVERVIEW

1.1 Product Overview and Scope of Sleeping Pills (Prescription Drugs)
1.2 Classification of Sleeping Pills (Prescription Drugs)
  1.2.1 EMEA Sleeping Pills (Prescription Drugs) Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Sleeping Pills (Prescription Drugs) Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Zolpidem
  1.2.4 Eszopiclone (Lunesta)
  1.2.5 Ramelteon (Rozerem)
  1.2.6 Ativan (lorazepam)
  1.2.7 Adapin (doxepin)
1.3 EMEA Sleeping Pills (Prescription Drugs) Market by Application/End Users
  1.3.1 EMEA Sleeping Pills (Prescription Drugs) Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
1.4 EMEA Sleeping Pills (Prescription Drugs) Market by Region
  1.4.1 EMEA Sleeping Pills (Prescription Drugs) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Sleeping Pills (Prescription Drugs) (2012-2022)
  1.5.1 EMEA Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2012-2022)

2 EMEA SLEEPING PILLS (PRESCRIPTION DRUGS) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Sleeping Pills (Prescription Drugs) Market Competition by Players/Manufacturers
  2.1.1 EMEA Sleeping Pills (Prescription Drugs) Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Sleeping Pills (Prescription Drugs) Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Sleeping Pills (Prescription Drugs) Sale Price by Players (2012-2017)
2.2 EMEA Sleeping Pills (Prescription Drugs) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Sleeping Pills (Prescription Drugs) Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Sleeping Pills (Prescription Drugs) Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Sleeping Pills (Prescription Drugs) Sale Price by Type (2012-2017)
2.3 EMEA Sleeping Pills (Prescription Drugs) (Volume) by Application
2.4 EMEA Sleeping Pills (Prescription Drugs) (Volume and Value) by Region
  2.4.1 EMEA Sleeping Pills (Prescription Drugs) Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Sleeping Pills (Prescription Drugs) Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Sleeping Pills (Prescription Drugs) Sales Price by Region (2012-2017)

3 EUROPE SLEEPING PILLS (PRESCRIPTION DRUGS) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Sleeping Pills (Prescription Drugs) Sales and Value (2012-2017)
  3.1.1 Europe Sleeping Pills (Prescription Drugs) Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2012-2017)
3.2 Europe Sleeping Pills (Prescription Drugs) Sales and Market Share by Type
3.3 Europe Sleeping Pills (Prescription Drugs) Sales and Market Share by Application
3.4 Europe Sleeping Pills (Prescription Drugs) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Sleeping Pills (Prescription Drugs) Sales Volume by Countries (2012-2017)
  3.4.2 Europe Sleeping Pills (Prescription Drugs) Revenue by Countries (2012-2017)
  3.4.3 Germany Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  3.4.4 France Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  3.4.5 UK Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  3.4.6 Russia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  3.4.7 Italy Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SLEEPING PILLS (PRESCRIPTION DRUGS) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Sleeping Pills (Prescription Drugs) Sales and Value (2012-2017)
  4.1.1 Middle East Sleeping Pills (Prescription Drugs) Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2012-2017)
4.2 Middle East Sleeping Pills (Prescription Drugs) Sales and Market Share by Type
4.3 Middle East Sleeping Pills (Prescription Drugs) Sales and Market Share by Application
4.4 Middle East Sleeping Pills (Prescription Drugs) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Sleeping Pills (Prescription Drugs) Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Sleeping Pills (Prescription Drugs) Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  4.4.4 Israel Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  4.4.5 UAE Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  4.4.6 Iran Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)

5 AFRICA SLEEPING PILLS (PRESCRIPTION DRUGS) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Sleeping Pills (Prescription Drugs) Sales and Value (2012-2017)
  5.1.1 Africa Sleeping Pills (Prescription Drugs) Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2012-2017)
5.2 Africa Sleeping Pills (Prescription Drugs) Sales and Market Share by Type
5.3 Africa Sleeping Pills (Prescription Drugs) Sales and Market Share by Application
5.4 Africa Sleeping Pills (Prescription Drugs) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Sleeping Pills (Prescription Drugs) Sales Volume by Countries (2012-2017)
  5.4.2 Africa Sleeping Pills (Prescription Drugs) Revenue by Countries (2012-2017)
  5.4.3 South Africa Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Sleeping Pills (Prescription Drugs) Sales and Growth Rate (2012-2017)

6 EMEA SLEEPING PILLS (PRESCRIPTION DRUGS) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Takeda Pharmaceutical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Apotex
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Aurobindo Pharma
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Actellon Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Allegiant Health
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cayman Chemical
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ambitropin
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Hayao
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Sleeping Pills (Prescription Drugs) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 SLEEPING PILLS (PRESCRIPTION DRUGS) MANUFACTURING COST ANALYSIS

7.1 Sleeping Pills (Prescription Drugs) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sleeping Pills (Prescription Drugs)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sleeping Pills (Prescription Drugs) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sleeping Pills (Prescription Drugs) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SLEEPING PILLS (PRESCRIPTION DRUGS) MARKET FORECAST (2017-2022)

11.1 EMEA Sleeping Pills (Prescription Drugs) Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Sleeping Pills (Prescription Drugs) Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Sleeping Pills (Prescription Drugs) Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Sleeping Pills (Prescription Drugs) Price and Trend Forecast (2017-2022)
11.2 EMEA Sleeping Pills (Prescription Drugs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Sleeping Pills (Prescription Drugs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Sleeping Pills (Prescription Drugs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Sleeping Pills (Prescription Drugs) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Sleeping Pills (Prescription Drugs) Sales Forecast by Type (2017-2022)
11.7 EMEA Sleeping Pills (Prescription Drugs) Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Sleeping Pills (Prescription Drugs)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Volume Market Share by Type (Product Category) in 2016
Figure Zolpidem Product Picture
Figure Eszopiclone (Lunesta) Product Picture
Figure Ramelteon (Rozerem) Product Picture
Figure Ativan (lorazepam) Product Picture
Figure Adapin (doxepin) Product Picture
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Sleeping Pills (Prescription Drugs) by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure EMEA Sleeping Pills (Prescription Drugs) Market Size (Million USD) by Region (2012-2022)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Sleeping Pills (Prescription Drugs) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales Share by Players (2012-2017)
Figure 2016 Sleeping Pills (Prescription Drugs) Sales Share by Players
Figure 2017 Sleeping Pills (Prescription Drugs) Sales Share by Players
Figure EMEA Sleeping Pills (Prescription Drugs) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue (Million USD) by Players (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue Share by Players (2012-2017)
Table 2016 EMEA Sleeping Pills (Prescription Drugs) Revenue Share by Players
Table 2017 EMEA Sleeping Pills (Prescription Drugs) Revenue Share by Players
Table EMEA Sleeping Pills (Prescription Drugs) Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales Share by Type (2012-2017)
Figure Sales Market Share of Sleeping Pills (Prescription Drugs) by Type (2012-2017)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sleeping Pills (Prescription Drugs) by Type in 2016
Table EMEA Sleeping Pills (Prescription Drugs) Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales Share by Application (2012-2017)
Figure Sales Market Share of Sleeping Pills (Prescription Drugs) by Application (2012-2017)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share by Application in 2016
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Sales Share by Region (2012-2017)
Figure Sales Market Share of Sleeping Pills (Prescription Drugs) by Region (2012-2017)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share in 2016
Table EMEA Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Sleeping Pills (Prescription Drugs) by Region (2012-2017)
Figure EMEA Sleeping Pills (Prescription Drugs) Revenue Market Share Regions in 2016
Table EMEA Sleeping Pills (Prescription Drugs) Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue and Growth Rate (2012-2017)
Table Europe Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2012-2017)
Table Europe Sleeping Pills (Prescription Drugs) Market Share by Type (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Market Share by Type in 2016
Table Europe Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2012-2017)
Table Europe Sleeping Pills (Prescription Drugs) Market Share by Application (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Market Share by Application in 2016
Table Europe Sleeping Pills (Prescription Drugs) Sales (K Units) by Countries (2012-2017)
Table Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Countries in 2016
Table Europe Sleeping Pills (Prescription Drugs) Revenue (Million USD) by Countries (2012-2017)
Table Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2016
Figure Germany Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure France Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure UK Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Market Share by Type (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Market Share by Type (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Sales (K Units) by Applications (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Market Share by Applications (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Sales Market Share by Application in 2016
Table Middle East Sleeping Pills (Prescription Drugs) Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Sales Volume Market Share by Countries in 2016
Table Middle East Sleeping Pills (Prescription Drugs) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Type in 2016
Table Africa Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Sales Volume (K Units) by Countries (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Countries (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Countries in 2016
Table Africa Sleeping Pills (Prescription Drugs) Revenue (Million USD) by Countries (2012-2017)
Table Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries (2012-2017)
Figure Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Countries in 2016
Figure South Africa Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Table Sanofi Sleeping Pills (Prescription Drugs) Basic Information List
Table Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Sanofi Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Sleeping Pills (Prescription Drugs) Basic Information List
Table Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Basic Information List
Table Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Apotex Sleeping Pills (Prescription Drugs) Basic Information List
Table Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Apotex Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Apotex Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Apotex Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Aurobindo Pharma Sleeping Pills (Prescription Drugs) Basic Information List
Table Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Aurobindo Pharma Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Basic Information List
Table Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Allegiant Health Sleeping Pills (Prescription Drugs) Basic Information List
Table Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Allegiant Health Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Allegiant Health Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Cayman Chemical Sleeping Pills (Prescription Drugs) Basic Information List
Table Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Cayman Chemical Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Cayman Chemical Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Ambitropin Sleeping Pills (Prescription Drugs) Basic Information List
Table Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Ambitropin Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Ambitropin Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Hayao Sleeping Pills (Prescription Drugs) Basic Information List
Table Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hayao Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate (2012-2017)
Figure Hayao Sleeping Pills (Prescription Drugs) Sales Market Share in EMEA (2012-2017)
Figure Hayao Sleeping Pills (Prescription Drugs) Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sleeping Pills (Prescription Drugs)
Figure Manufacturing Process Analysis of Sleeping Pills (Prescription Drugs)
Figure Sleeping Pills (Prescription Drugs) Industrial Chain Analysis
Table Raw Materials Sources of Sleeping Pills (Prescription Drugs) Major Manufacturers in 2016
Table Major Buyers of Sleeping Pills (Prescription Drugs)
Table Distributors/Traders List
Figure EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Sleeping Pills (Prescription Drugs) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Sleeping Pills (Prescription Drugs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Sleeping Pills (Prescription Drugs) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Sleeping Pills (Prescription Drugs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Sleeping Pills (Prescription Drugs) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Sleeping Pills (Prescription Drugs) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Sleeping Pills (Prescription Drugs) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Sleeping Pills (Prescription Drugs) Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Sleeping Pills (Prescription Drugs) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources